Form 4: Opus Genetics CEO Sells Shares
Insider Transaction (Form 4)
George Magrath, Chief Executive Officer and a Director of Opus Genetics, Inc., sold 9,475 shares of common stock on July 23, 2026 for $2.95 per share.
Summary
- Open-market sale: disposed of 9,475 Common Stock at $2.95 ($27,926) on July 23, 2026; holds 1,731,869 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $27,926 of stock on the open market.
Insider Transactions
George Magrath — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-23 | Open-market sale | Common Stock | 9,475 | $3 | $27.9K | 1,731,869 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-23 | Open-market sale (9,475 shares) |
Keywords
insider transaction, Form 4, IRD, Opus Genetics, Inc., bearish, George Magrath
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.